Luteolin-loading of Her-2-poly (lactic-co-glycolic acid) nanoparticles and proliferative inhibition of gastric cancer cells via targeted regulation of forkhead box protein O1

Conclusion: Luteolin-loading of Her-2-NPs could potentially be used as a novel anti-cancer drugs for targeted cancer therapy.

Source: Journal of Cancer Research and Therapeutics - May 27, 2020 Category: Cancer & Oncology Authors: Jian Ding Qiu Li ShanShan He Jie Xie XiaoFei Liang Ting Wu Dan Li Source Type: research